End-of-day quote
Korea S.E.
18:00:00 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
87,600
KRW
|
+1.98%
|
|
+4.04%
|
-12.75%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
13,234,939
|
7,612,048
|
5,646,385
|
7,862,650
|
6,915,060
|
-
|
-
|
Enterprise Value (EV)
2 |
12,865
|
7,293
|
5,353
|
7,863
|
6,770
|
6,654
|
6,623
|
P/E ratio
|
-49
x
|
117
x
|
-40.5
x
|
-239
x
|
216
x
|
52.9
x
|
37
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
0.06%
|
Capitalization / Revenue
|
515
x
|
18.2
x
|
22.9
x
|
22.2
x
|
14.3
x
|
10.6
x
|
8.57
x
|
EV / Revenue
|
501
x
|
17.4
x
|
21.7
x
|
22.2
x
|
14
x
|
10.2
x
|
8.21
x
|
EV / EBITDA
|
-55.6
x
|
68.4
x
|
-45.3
x
|
-354
x
|
115
x
|
35.5
x
|
25.6
x
|
EV / FCF
|
-58
x
|
-75
x
|
-32.5
x
|
-
|
191
x
|
56.7
x
|
64.9
x
|
FCF Yield
|
-1.72%
|
-1.33%
|
-3.08%
|
-
|
0.52%
|
1.76%
|
1.54%
|
Price to Book
|
34.9
x
|
17.1
x
|
17.8
x
|
-
|
21.7
x
|
16
x
|
11.8
x
|
Nbr of stocks (in thousands)
|
78,313
|
78,313
|
78,313
|
78,313
|
78,313
|
-
|
-
|
Reference price
3 |
169,000
|
97,200
|
72,100
|
100,400
|
88,300
|
88,300
|
88,300
|
Announcement Date
|
21-02-08
|
22-02-08
|
23-02-09
|
24-01-29
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
123.9
|
25.69
|
418.6
|
246.2
|
354.9
|
485
|
650.6
|
806.6
|
EBITDA
1 |
-
|
-231.2
|
106.6
|
-118.1
|
-22.2
|
58.83
|
187.3
|
258.2
|
EBIT
1 |
-
|
-239.5
|
94.96
|
-131.1
|
-37.09
|
42.68
|
166.4
|
280.1
|
Operating Margin
|
-
|
-932.32%
|
22.68%
|
-53.24%
|
-10.45%
|
8.8%
|
25.58%
|
34.73%
|
Earnings before Tax (EBT)
1 |
-
|
-240.2
|
71.28
|
-142.5
|
-42.58
|
38.55
|
152.1
|
243.4
|
Net income
1 |
-
|
-247.7
|
64.85
|
-139.4
|
-33.93
|
31.69
|
118.3
|
186.9
|
Net margin
|
-
|
-964.34%
|
15.49%
|
-56.64%
|
-9.56%
|
6.53%
|
18.19%
|
23.17%
|
EPS
2 |
-1,100
|
-3,448
|
828.0
|
-1,780
|
-420.0
|
408.1
|
1,670
|
2,386
|
Free Cash Flow
3 |
-
|
-221,749
|
-97,188
|
-164,831
|
-
|
35,530
|
117,336
|
102,000
|
FCF margin
|
-
|
-863,221.34%
|
-23,214.67%
|
-66,955.81%
|
-
|
7,326.15%
|
18,035.72%
|
12,645.69%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
60,393.99%
|
62,636.58%
|
39,499.76%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
112,117.74%
|
99,161.96%
|
54,581.37%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
50.00
|
Announcement Date
|
20-04-14
|
21-02-08
|
22-02-08
|
23-02-09
|
24-01-29
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
164
|
23.95
|
230.7
|
41.14
|
53.43
|
88.83
|
62.77
|
60.78
|
77.01
|
90.34
|
126.8
|
107.8
|
115.2
|
126
|
137.2
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
15.1
|
13.8
|
17.5
|
21.2
|
-
|
EBIT
1 |
10.85
|
-49.94
|
134.4
|
-37.14
|
-40.07
|
-9.247
|
-44.62
|
-22.66
|
-18.94
|
-10.71
|
15.21
|
5.988
|
6.575
|
13.31
|
18.18
|
-
|
Operating Margin
|
6.62%
|
-208.5%
|
58.23%
|
-90.26%
|
-74.99%
|
-10.41%
|
-71.09%
|
-37.27%
|
-24.59%
|
-11.86%
|
12%
|
5.55%
|
5.7%
|
10.56%
|
13.25%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-44.5
|
52.68
|
-35.01
|
-
|
-16.62
|
-46.55
|
-2.494
|
-25.05
|
-19.82
|
4.796
|
1.775
|
1.3
|
10.57
|
15.17
|
-
|
Net income
1 |
61.99
|
-44.27
|
47.13
|
-35.21
|
-
|
-14.96
|
-43.86
|
-2.369
|
-23.34
|
-13.93
|
5.708
|
2.9
|
2.4
|
10.8
|
14.74
|
-
|
Net margin
|
37.81%
|
-184.85%
|
20.42%
|
-85.56%
|
-
|
-16.84%
|
-69.88%
|
-3.9%
|
-30.31%
|
-15.42%
|
4.5%
|
2.69%
|
2.08%
|
8.57%
|
10.75%
|
-
|
EPS
2 |
-
|
-
|
-
|
-450.0
|
-580.0
|
-191.0
|
-560.0
|
-30.00
|
-298.0
|
-235.0
|
86.00
|
-32.91
|
15.63
|
152.0
|
186.0
|
159.7
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-08-10
|
21-11-11
|
22-02-08
|
22-05-16
|
22-08-11
|
22-11-10
|
23-02-09
|
23-05-10
|
23-08-10
|
23-11-09
|
24-01-29
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
370
|
319
|
293
|
-
|
145
|
261
|
292
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
-
|
-221,749
|
-97,188
|
-164,831
|
-
|
35,530
|
117,336
|
102,000
|
ROE (net income / shareholders' equity)
|
-
|
-135%
|
19.8%
|
-36.7%
|
-
|
10.7%
|
32.2%
|
37.3%
|
ROA (Net income/ Total Assets)
|
-
|
-77.1%
|
11.3%
|
-21.3%
|
-
|
4.64%
|
14.7%
|
20.2%
|
Assets
1 |
-
|
321.3
|
571.9
|
653.9
|
-
|
683.7
|
803.1
|
925.1
|
Book Value Per Share
3 |
-
|
4,840
|
5,672
|
4,042
|
-
|
4,060
|
5,518
|
7,464
|
Cash Flow per Share
3 |
-
|
-2,936
|
-
|
-2,042
|
-
|
688.0
|
1,699
|
2,377
|
Capex
1 |
-
|
11
|
4.32
|
4.91
|
-
|
8.15
|
7.73
|
10.1
|
Capex / Sales
|
-
|
42.91%
|
1.03%
|
1.99%
|
-
|
1.68%
|
1.19%
|
1.26%
|
Announcement Date
|
20-04-14
|
21-02-08
|
22-02-08
|
23-02-09
|
24-01-29
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
88,300
KRW Average target price
106,133
KRW Spread / Average Target +20.20% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.75% | 4.96B | | +4.30% | 69.17B | | +12.55% | 9.06B | | +42.38% | 4.47B | | +5.23% | 3.9B | | +21.52% | 2.41B | | -19.05% | 2.41B | | -28.72% | 2.23B | | +11.13% | 2.02B | | +4.60% | 1.65B |
Specialty & Advanced Pharmaceuticals
|